Shah Ayesha, Talley Nicholas J, Walker Marjorie, Koloski Natasha, Morrison Mark, Burger Daniel, Andrews Jane M, McGuckin Michael, Jones Mike, Holtmann Gerald
Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Faculty of Medicine and Faculty of Health and Behavioural Sciences, Translational Research Institute, University of Queensland, Ipswich Road, Woolloongabba, Brisbane, QLD, Australia.
Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia.
Dig Dis Sci. 2017 Sep;62(9):2472-2480. doi: 10.1007/s10620-017-4496-z. Epub 2017 Mar 9.
Case control studies suggest an inverse association between Helicobacter pylori (H. pylori) and Crohn's disease (CD). It is possible this could be accounted for by confounders such as antibiotic therapy. Analyzing the geographic distribution of H. pylori and the links with the incidence and prevalence of CD would be an alternative approach to circumvent these confounders.
The literature was searched for studies published between 1990 and 2016 that reported incidence or prevalence data for CD in random population samples in developed countries (GDP per capita >20,000 USD/year). Corresponding prevalence studies for H. pylori in these same regions were then sought matched to the same time period (±6 years). The association between the incidence and prevalence of CD and H. pylori prevalence rates were assessed before and after adjusting for GDP and life expectancy.
A total of 19 CD prevalence and 22 CD incidence studies from 10 European countries, Japan, USA, and Australia with date-matched H. pylori prevalence data were identified. The mean H. pylori prevalence rate was 43.4% (range 15.5-85%), and the mean rates for incidence and prevalence for CD were 6.9 and 91.0/100,000 respectively. The incidence (r = -0.469, p < 0.03) and prevalence (r = -0.527, p = 0.02) of CD was inversely and significantly associated with prevalence of H. pylori infection.
Our data demonstrate a significant inverse association between geographic distribution of H. pylori and CD. Thus, it is highly unlikely that the findings of previous case control studies were simply due to confounding factors such as concomitant antibiotic use in CD patients.
病例对照研究表明幽门螺杆菌(H. pylori)与克罗恩病(CD)之间存在负相关。这可能是由抗生素治疗等混杂因素导致的。分析幽门螺杆菌的地理分布及其与克罗恩病发病率和患病率的关联,可能是规避这些混杂因素的另一种方法。
检索1990年至2016年间发表的研究,这些研究报告了发达国家(人均国内生产总值>20,000美元/年)随机人群样本中克罗恩病的发病率或患病率数据。然后寻找这些相同地区同时期(±6年)对应的幽门螺杆菌患病率研究。在调整国内生产总值和预期寿命前后,评估克罗恩病发病率和患病率与幽门螺杆菌患病率之间的关联。
共确定了来自10个欧洲国家、日本、美国和澳大利亚的19项克罗恩病患病率研究和22项克罗恩病发病率研究,以及与之日期匹配的幽门螺杆菌患病率数据。幽门螺杆菌平均患病率为43.4%(范围15.5 - 85%),克罗恩病的发病率和患病率平均分别为6.9/100,000和91.0/100,000。克罗恩病的发病率(r = -0.469,p < 0.03)和患病率(r = -0.527,p = 0.02)与幽门螺杆菌感染患病率呈显著负相关。
我们的数据表明幽门螺杆菌的地理分布与克罗恩病之间存在显著负相关。因此,先前病例对照研究的结果极不可能仅仅是由于克罗恩病患者同时使用抗生素等混杂因素导致的。